Clinical Trial Update: A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment [Phase 4]

View source ↗

Summary

Phase 4 long-term extension study for participants with treatment-resistant major depressive disorder continuing esketamine nasal spray; results have been poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine nasal spray (esketamine)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2025-09-18